Luminal progenitors are of immediate interest as the cell‐of‐origin for aggressive cancers in BRCA1 mutation carriers and targeted risk reduction (Al‐Hajj et al, 2003; Lim et al, 2009; Keller et al, 2012; Visvader & Stingl, 2014). Here, BRCA1 is linked to cancer.